Single-Cell Omics Analysis Reveals Critical Cell Subtypes and their Functional Attributes in Myocardial Ischemia-Reperfusion Injury
en-GBde-DEes-ESfr-FR

Single-Cell Omics Analysis Reveals Critical Cell Subtypes and their Functional Attributes in Myocardial Ischemia-Reperfusion Injury

06/02/2026 Compuscript Ltd

https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2025-0159
Announcing a new article publication for BIO Integration journal. Cardiac cell death and myocardial fibrosis after ischemia-reperfusion (I/R) injury are the primary causes of impaired cardiac function. Despite advances in therapies targeting ischemia, fibrosis, and angiogenesis, the early molecular and cellular mechanisms driving I/R injury remain poorly defined, particularly regarding interactions between specific cardiomyocyte (CM) subtypes and stromal cells. Extensive signaling interactions have been demonstrated between myocardial cells and fibroblasts during injury repair and remodeling, but the dynamic characteristics and molecular pathways involved in early I/R stages remain to be fully elucidated. The authors of this article used single-cell transcriptomics to identify a key subtype of CMs, termed C0 Atcayos+ CMs, that are activated in I/R. Components of the Bmp6–(Bmpr1a+Bmpr2) and Fgf1–Fgfr1 signaling axes were highly expressed and mediated interactions between the C0 Atcayos+ CM subtype and fibroblasts. These pathways are known to promote angiogenesis and regulate endothelial homeostasis, and to be crucial in inhibiting myocardial fibrosis. Ligand-receptor interaction network visualization suggested that communication between C0 Atcayos+ CMs and fibroblasts might be a critical link in the transition from myocardial cell death to fibrosis after I/R. Targeting these signaling axes might therefore offer new strategies to impede fibrosis progression and improve cardiac function after I/R. This research provides a potential reference for inhibiting the progression of diseases such as myocardial fibrosis after I/R.
# # # # # #
BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.

Please visit www.bio-integration.org to learn more about the journal.
Editorial Board: https://bio-integration.org/editorial-board/

BIOI is available on the ScienceOpen platform (https://www.scienceopen.com/search#collection/55f45bac-fd64-431c-9fe7-50fd6a7f8781).

Submissions may be made using ScholarOne (https://mc04.manuscriptcentral.com/bioi).
There are no author submission or article processing fees.

Follow BIOI on Twitter @JournalBio; Facebook (https://www.facebook.com/BIO-Integration-Journal-108140854107716/) and LinkedIn (https://www.linkedin.com/company/bio-integration-journal/).

ISSN 2712-0074
eISSN 2712-0082

Wenyang Nie, Junhao Yan and Zibo Xie et al. Single-Cell Omics Analysis Reveals Critical Cell Subtypes and their Functional Attributes in Myocardial Ischemia-Reperfusion Injury. BIOI. 2026. Vol. 7(1). DOI: 10.15212/bioi-2025-0159
# # # # # #
Wenyang Nie, Junhao Yan and Zibo Xie et al. Single-Cell Omics Analysis Reveals Critical Cell Subtypes and their Functional Attributes in Myocardial Ischemia-Reperfusion Injury. BIOI. 2026. Vol. 7(1). DOI: 10.15212/bioi-2025-0159
06/02/2026 Compuscript Ltd
Regions: Europe, Ireland
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement